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Abstract: Human Campylobacter infections are emerging worldwide and constitute significant health
burdens. We recently showed that the immunopathological sequelae in Campylobacter jejuni-infected mice
wereduetoToll-likereceptor (TLR)-4dependent immuneresponses inducedbybacterial lipooligosaccharide
(LOS). Information regarding the molecular mechanisms underlying Campylobacter coli-host interactions are
scarce, however. Therefore, we analyzed C. coli-induced campylobacteriosis in secondary abiotic IL-10−/−
mice with and without TLR4. Mice were infected perorally with a human C. coli isolate or with a murine
commensal Escherichia coli as apathogenic, non-invasive control. Independent from TLR4, C. coli and E. coli
stably colonized the gastrointestinal tract, but only C. coli induced clinical signs of campylobacteriosis.
TLR4−/− IL-10−/− mice, however, displayed less frequently fecal blood and less distinct histopathological
and apoptotic sequelae in the colon versus IL-10−/− counterparts on day 28 following C. coli infection.
Furthermore, C. coli-induced colonic immune cell responses were less pronounced in TLR4−/− IL-10−/− as
compared to IL-10−/− mice and accompanied by lower pro-inflammatory mediator concentrations in the
intestines and the liver of the former versus the latter. In conclusion, our study provides evidence that
TLR4 is involved in mediating C. coli-LOS-induced immune responses in intestinal and extra-intestinal
compartments during murine campylobacteriosis.
Keywords: Toll-like receptor-4; lipooligosaccharide; Campylobacter coli; campylobacteriosis model;
host-pathogen interaction; secondary abiotic IL-10−/− mice; pro-inflammatory immune responses;
intestinal immunopathology; extra-intestinal immune responses
1. Introduction
Campylobacter infections are among the most prevalent causes of bacterial infectious gastroenteritis
worldwide [1,2]. In most cases, C. jejuni and, less frequently, C. coli induce the diarrheal disease
complex campylobacteriosis in infected human patients. The acute phase of campylobacteriosis
is characterized by diarrhea and abdominal cramps, commonly accompanied by fever and bloody
stools [3,4]. The disease is mostly self-limiting, and antimicrobial therapy is, therefore, only needed in
severe incidents, particularly in infected immunocompromised individuals. In rare cases, however,
campylobacteriosis is associated with long-term post-infectious sequelae, such as the autoimmune
diseases Guillain–Barré syndrome (GBS), reactive arthritis, or intestinal inflammatory morbidities,
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including inflammatory bowel disease, coeliac disease, and irritable bowel syndrome [4–6]. The majority
of campylobacteriosis outbreaks are food-borne due to the fact that Campylobacter species reside as
commensals in the gut microbiota of several domestic and wild animals [6,7]. Besides contaminated
water, raw or undercooked meat from livestock, such as poultry, cattle, pigs, and sheep, are common
sources of C. jejuni and C. coli transmission to humans [8,9]. Although C. jejuni and C. coli share many
reservoirs, their prevalence rates differ greatly. In contaminated sheep and pig meat, for instance,
most Campylobacter isolates have been identified as C. coli [8,10]. Even though C. coli causes far fewer
infections than C. jejuni, its health burden is still considerable. Depending on the geographical region,
C. coli can account for up to 25% of reported Campylobacter infections [11]. Data collected in the
framework of a population-based sentinel surveillance scheme for Campylobacter infections in the
United Kingdom revealed, for instance, that C. coli was the causative agent in 25,000 gastroenteritis
cases with 11 lethal outcomes [12].
The innate host immune system is pivotal in combating bacterial infections [13]. Whereas the
accurate spatial and temporal regulation of the innate immune response is crucial for the host to
successfully eliminate the pathogen, overamplification or dysregulation of the pathogen-induced
inflammation results in disrupted intestinal homeostasis and, consequently, the development of
immunopathology [14]. Under certain circumstances, Gram-negative bacterial infections may result
in sepsis with the lethal outcome due to an uncontrolled release of pro-inflammatory mediators
following activation of the innate immune receptor Toll-like receptor (TLR)-4 by lipopolysaccharide
(LPS) or lipooligosaccharide (LOS), both constituting major cell wall components of Gram-negative
bacteria [15]. We and others have previously shown that TLR4 signaling induced by LOS is essential for
the intestinal and extra-intestinal, including systemic, immunopathological host responses following
murine C. jejuni infection [16–20]. Clinical studies confirmed the important role of bacterial LOS in
intestinal pathogenesis and that modification of LOS increases the pathogenic potential of C. jejuni [21].
In particular, LOS sialylation is associated with severe gastroenteritis and supports the induction
and progression of severe forms of campylobacteriosis, including the development of post-infectious
sequelae. Both LPS and LOS consist of a core oligosaccharide and a lipid A component, but LOS
lacks the prolonged O-antigens found in LPS [22]. Lipid A, however, is responsible for most of the
immunostimulatory effects of LPS and LOS [23]. Despite the significance of LOS in the pathogenicity of
campylobacteriosis, only very little is known about the genetic and phenotypic diversity of C. coli LOS
and its pathogenic properties in intestinal infection [24]. Recent studies revealed a high genetic diversity
of LOS among C. coli strains isolated from different sources, assigning the LOS to 12 different genetic
subtypes [24–26]. Furthermore, species-specific phenotypic features of C. coli could be identified,
which might possibly explain differences between C. jejuni and C. coli in terms of host adaptation [24].
As a result of the predominance of C. jejuni in human campylobacteriosis, research on C. coli
has largely been neglected [12]. Moreover, the clinical symptoms induced by C. coli are considered
to be indistinguishable from those following C. jejuni infection [11]. Given that our knowledge of
mechanisms underlying C. coli-host interactions is rather scarce, we here investigated C. coli-induced
campylobacteriosis in an established clinical murine infection model. Our group recently showed that
upon microbiota depletion by broad-spectrum antibiotic treatment, secondary abiotic IL-10−/− mice could
not only be stably colonized by C. jejuni following peroral challenge but also presented with key features
of acute campylobacteriosis seen in humans, such as wasting and bloody diarrhea within one week [27].
The underlying mechanisms for these severe C. jejuni-induced immunopathological responses mounting
in acute ulcerative enterocolitis were the abrogated colonization resistance following microbiota depletion,
facilitating the establishment of the pathogen in the host’s gastrointestinal tract, and furthermore, the lack
of IL-10, enhancing the susceptibility of mice to C. jejuni LOS [27]. Therefore, microbiota-depleted and
C. jejuni-infected IL-10−/− mice display pronounced TLR4-dependent LOS-induced innate and adaptive
immune responses that are not restricted to the intestinal tract but can also be observed in extra-intestinal,
including systemic, compartments [17,28–35]. Very recently, we were able to show that TLR4-deficient
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IL-10−/− mice carrying a human gut microbiota displayed less distinct immune responses upon peroral
C. coli infection as compared to IL-10−/− counterparts [36].
In order to investigate C. coli-induced campylobacteriosis and to determine the immunopathogenic
role of C. coli LOS in the absence of any commensal gut microbiota, we here assessed the gastrointestinal
colonization properties and the clinical, macroscopic, and microscopic inflammatory sequelae
in intestinal and extra-intestinal compartments following peroral challenge of secondary abiotic
TLR4-deficient IL-10−/− mice.
2. Materials and Methods
2.1. Ethics Statement
The mouse studies were approved by the local commission for animal experiments (“Landesamt
für Gesundheit und Soziales”, LaGeSo, Berlin, Germany, registration numbers G0172/16 and G0247/16)
and performed according to the European Guidelines for animal welfare (2010/63/EU). Throughout the
experiment, the clinical conditions of mice were evaluated twice daily.
2.2. Generation of Secondary Abiotic Mice
IL-10−/− and TLR4−/− IL-10−/− mice (in C57BL/10 background) were raised under specific
pathogen-free conditions in the identical room within the Forschungseinrichtungen für Experimentelle
Medizin (FEM, Charité—University Medicine Berlin, Berlin, Germany). Mice were maintained in
cages covered with filter tops under standard conditions (12 h light/12 dark cycle, 55 ± 15% humidity,
22–24 ◦C room temperature), had unlimited access to autoclaved standard chow (ssniff R/M-H,
V1534-300, Sniff, Soest, Germany), and were handled under aseptic conditions inside an experimental
intermediate barrier level. In order to guarantee stable gastrointestinal C. coli or E. coli colonization [16],
the physiological murine colonization resistance was abrogated by antibiotic microbiota depletion,
as described earlier [16,37]. In brief, immediately after weaning, 3-week-old mice were subjected to an
eight-week course of broad-spectrum antibiotic treatment by adding ampicillin plus sulbactam (1 g/L;
Ratiopharm, Ulm, Germany), vancomycin (500 mg/L; Cell Pharm, Hannover, Germany), ciprofloxacin
(200 mg/L; Bayer Vital, Leverkusen, Germany), imipenem (250 mg/L; Fresenius Kabi, Bad Homburg,
Germany), and metronidazole (1 g/L; B. Braun, Melsungen, Germany) to the autoclaved drinking
water (ad libitum) [37]. To assure antibiotic irrigation, the antibiotic cocktail was replaced by autoclaved
drinking water three days prior to bacterial gavage of secondary abiotic mice.
2.3. Bacterial Challenge and Gastrointestinal Colonization and Translocation
The used C. coli strain had originally been isolated from the stool of a patient suffering from
bloody diarrhea and was kindly provided by Dr. Torsten Semmler (Robert-Koch-Institute, Berlin,
Germany). A commensal intestinal Escherichia coli isolate from a healthy wildtype mouse served as a
Gram-negative rod control [38,39]. The absence of commonly known virulence factors of pathogenic
E. coli, such as stx 1 and 2, catA, hlyA, cspA, katP, and astA, was verified by PCR analysis [39].
On two consecutive days (i.e., days 0 and 1), sex- and age-matched secondary abiotic mice
(three months of age) were perorally challenged with 109 colony forming units (CFU) of the C. coli
patient isolate or the commensal E. coli strain by gavage. Throughout the experiment, mice were
maintained in a sterile environment (autoclaved food and drinking water) and handled under strict
aseptic conditions to prevent contamination.
To monitor the colonization properties over a 28-day-period, C. coli and E. coli loads were
enumerated in fecal samples collected on selected days post-infection (p.i.) and in luminal samples
derived from distinct parts of the gastrointestinal tract (i.e., from the stomach, duodenum, ileum,
and colon) upon necropsy by culture, as stated elsewhere [16,40]. In order to quantity C. coli burdens,
samples were homogenized with a sterile pistil and serial dilutions plated onto Columbia agar plates
containing 5% sheep blood and, additionally, onto selective Karmali plates (both from Oxoid, Wesel,
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Germany). The inoculated plates were incubated in a jar under microaerophilic conditions for 48 h
at 37 ◦C. E. coli loads were enumerated in serial dilutions of homogenized fecal samples plated onto
Columbia agar plates containing 5% sheep blood and selective MacConkey agar plates (Oxoid, Wesel,
Germany) following incubation for 48 h at 37 ◦C in aerobic atmosphere. Bacterial translocation
of the respective bacterial strains was assessed in homogenized ex vivo biopsies obtained from
mesenteric lymph nodes (MLN), spleen, kidneys, liver, and lungs and from cardiac blood, as described
elsewhere [16,40]. The detection limit of viable pathogens was ≈ 100 CFU per g (CFU/g).
2.4. Clinical Conditions
Before and after bacterial application, the clinical conditions of mice were evaluated by daily applying
a standardized clinical score (maximum 12 points). The score addressed the clinical aspect/wasting
(0: normal; 1: ruffled fur; 2: less locomotion; 3: isolation; 4: severely compromised locomotion, pre-final
aspect), the abundance of blood in feces (0: no blood; 2: microscopic detection of blood by the Guajac
method using Hemoccult, Beckman Coulter, Krefeld, Germany; 4: macroscopic blood visible), and diarrhea
(0: formed feces; 2: pasty feces; 4: liquid feces), as described earlier [33]. Fecal blood positivity rates
were determined by the ratio of overt and occult fecal blood positive mice to the total number of
analyzed animals.
2.5. Sampling Procedures
On day 28 p.i., mice were sacrificed by CO2 asphyxiation. Immediately after, ex vivo biopsies
from spleen, kidneys, liver, lungs, and MLN, as well as luminal gastrointestinal samples (from the
stomach, duodenum, ileum, and colon), were isolated under sterile conditions. Cardiac blood was
obtained for serum cytokine measurements. Colon, MLN, and liver tissue samples were collected from
each mouse for subsequent immunological, histological, and microbiological analyses.
2.6. Histopathology
Histological analyses were performed in colonic ex vivo biopsies following immediate fixation in
5% formalin and embedding in paraffin. Sections (5 µm) were stained with hematoxylin and eosin
(H&E), examined by light microscopy (100× magnification), and histopathological changes in the
large intestines were quantitatively assessed by applying an established histopathological scoring
system, as reported previously [41]: Score 1: minimal inflammatory cell infiltrates in the mucosa with
intact epithelium. Score 2: mild inflammatory cell infiltrates in the mucosa and submucosa with mild
hyperplasia and mild goblet cell loss. Score 3: moderate inflammatory cell infiltrates in the mucosa
with moderate goblet cell loss. Score 4: marked inflammatory cell infiltration into the mucosa and
submucosa with marked goblet cell loss, multiple crypt abscesses, and crypt loss.
2.7. In Situ Immunohistochemistry
The distinct immune cell population was quantified in colonic paraffin sections by applying
in situ immunohistochemistry, as described earlier [42–45]. In brief, apoptotic epithelial cells,
macrophages/monocytes, T lymphocytes, regulatory T cells (Tregs), and B lymphocytes were detected
in 5 µm colonic paraffin sections stained with primary antibodies directed against cleaved caspase 3
(Asp175, Cell Signaling, Beverly, MA, USA, 1:200), F4/80 (# 14-4801, clone BM8, eBioscience, San Diego,
CA, USA, 1:50), CD3 (#N1580, Dako, 1:10), FOXP3 (clone FJK-165, #14-5773, eBioscience, 1:100),
and B220 (No. 14-0452-81, eBioscience; 1:200), respectively. Positively stained cells were then examined
by light microscopy (magnification 100× and 400×), and for each mouse, the average number of
respective positively stained cells was determined within at least six high power fields (HPF, 0.287 mm2,
400×magnification) by a blinded investigator.
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2.8. Pro-Inflammatory Mediator Measurements in Intestinal, Extra-Intestinal, and Systemic Compartments
Ex vivo biopsies obtained from the colon (longitudinally cut strips of approximately 1 cm2),
MLN (3 lymph nodes), and liver (approximately 1 cm3) were washed in phosphate-buffered saline
(PBS; Thermo Fisher Scientific, Waltham, MA, USA) and placed into 24-flat-bottom well culture plates
(Thermo Fisher Scientific, Waltham, MA, USA) containing 500 µL serum-free RPMI 1640 medium
(Thermo Fisher Scientific, Waltham, MA, USA) supplemented with penicillin (100 µg/mL) and
streptomycin (100 µg/mL; Biochrom, Berlin, Germany). After incubation at 37 ◦C for 18 h, respective
culture supernatants, as well as serum samples, were tested for interferon-γ (IFN-γ) and tumor necrosis
factor-α (TNF-α) by the Mouse Inflammation Cytometric Bead Assay (CBA; BD Biosciences, Heidelberg,
Germany) in a BD FACSCanto II flow cytometer (BD Biosciences, Heidelberg, Germany). Nitric oxide
(NO) was measured by the Griess reaction, as described elsewhere [37].
2.9. Statistical Analysis
Medians and levels of significance were determined with GraphPad Prism v8, USA. The Student’s
t-test was used for pairwise comparisons of normally distributed data, and the Mann–Whitney test
was used for pairwise comparisons of not normally distributed data. For multiple comparisons,
the one-sided ANOVA with Tukey post-correction was used for normally distributed data, and the
Kruskal–Wallis test with Dunn’s post-correction for not normally distributed data. Two-sided
probability p-values ≤ 0.05 were considered significant. Data were pooled from three independent
experiments with the following cohort sizes per individual experiment: IL-10−/− mice +E. coli (4,3,3);
TLR4−/− IL-10−/− mice +E. coli (5,4,4); IL-10−/− mice +C. coli (6,5,5); TLR4−/− IL-10−/− mice +C. coli
(8,7,7). Definite outliers were removed after identification by using Grubb’s test (α = 0.001).
3. Results
3.1. Role of TLR4 in Intestinal Colonization of C. coli and E. coli in Secondary Abiotic IL-10−/−Mice
We first surveyed the intestinal colonization properties of pathogenic C. coli and commensal
E. coli following oral challenge of secondary abiotic IL-10−/− mice with or without TLR4. Our cultural
analyses revealed stable intestinal colonization efficiencies of either strain that was TLR4-independent,
as indicated by high median fecal loads of more than 108 viable bacterial cells per g feces in both IL-10−/−
mice lacking TLR4 and IL-10−/− counterparts (Figure 1). From day 2 until day 28 post-challenge,
fecal C. coli numbers marginally decreased by approximately 1.0–1.5 orders in mice of either genotype
(p < 0.01–0.001; Figure 1C,D).
Upon necropsy, comparable E. coli numbers could be cultivated from luminal samples taken from
stomach, duodenum, ileum, and colon of TLR4−/− IL-10−/− as compared to IL-10−/−mice (not significant
(n.s.); Figure 2A), which also held true for C. coli, except for gastric luminal C. coli loads that were
approximately two orders of magnitude higher in the former as compared to the latter at day 28
post-challenge (p < 0.001; Figure 2B). Furthermore, no viable C. coli or E. coli could be isolated from
extra-intestinal tissue sites, such as liver, kidneys, lungs, and cardiac blood (data not shown). Hence,
upon peroral application, C. coli and E. coli stably colonized the murine gastrointestinal tract at high
loads in a TLR4-independent fashion.
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Figure 1. Kinetic survey of fecal loads following peroral E. coli or C. coli application to secondary
abiotic IL-10−/− mice lacking TLR4. Secondary abiotic IL-10−/− mice ((A,C) open symbols) and IL-10−/−
mice lacking TLR4 ((B,D) TLR4−/− IL-10−/−; closed symbols) were perorally challenged with either a
commensal murine E. coli strain ((A,B) squares) or a C. coli patient isolate ((C,D) circles) on the day (d)
0 and d1. Intestinal colonization properties were quantitatively surveyed over time in fecal samples
taken post-infection by culture (in colony-forming units per g; CFU/g). Medians (black bars), levels of
significance (p-values) as determined by the Kruskal–Wallis test and Dunn’s post-correction, and
numbers of culture-positive mice out of the total number of analyzed animals (in parentheses) are given.
Data were pooled from three independent experiments. IL-10, interleukin-10; TLR4, Toll-like receptor-4.
Microorgani ms 2020, 8, x FOR PEER REVIEW 6 of 17 
 
mice lacking TLR4 ((B,D) TLR4-/- IL-10-/-; closed symbols) were perorally challenged with either a 
commensal murine E. coli strain ((A,B) squares) or a C. coli patient isolate ((C,D) circles) on the day 
(d) 0 and d1. Intestinal colonization properties were quantitatively surveyed over time in fecal 
samples taken post-infection by culture (in colony-forming units per g; CFU/g). Medians (black bars), 
levels of significance (p-values) as determined by the Kruskal–Wallis test and Dunn’s post-correction, 
and numbers of culture-positive mice out of the total number of analyzed animals (in parentheses) 
are given. Data were pooled from three independent experiments. IL-10, interleukin-10; TLR4, Toll-
like receptor-4. 
Upon necropsy, comparable E. coli numbers could be cultivated from luminal samples taken 
from stomach, duodenum, ileum, and colon of TLR4-/- IL-10-/- as compared to IL-10-/- mice (not 
significant (n.s.); Figure 2A), which also held true for C. coli, except for gastric luminal C. coli loads 
that w re approximately two ord rs f magnit de higher in the former as comp red to the latter at 
day 28 post-challenge (p < 0.001; Figure 2B). Furthermore, no viable C. coli or E. coli could be isolated 
from extra-i testinal tissue sites, such as liver, kid eys, lungs, and cardiac b ood (data not shown). 
Hence, upon peroral application, C. coli and E. coli stably colonized the murine gastrointestinal tract 
at high loads in a TLR4-independent fashion. 
 
Figure 2. Gastrointestinal C. coli and E. coli loads following peroral E. coli or C. coli application to 
secondary abiotic IL-10-/- mice lacking TLR4. Secondary abiotic IL-10-/- mice (open symbols) and IL-Figure 2. Gastrointestinal C. coli and E. oli loads foll wing peroral E. coli or C. coli application to
secondary abiotic IL-10−/− mice lacking TLR4. Secondary abiotic IL-10−/− mice (open symbols) and
IL-10−/− mice lacking TLR4 (TLR4−/− IL-10−/−; closed symbols) were perorally challenged with either
a commensal murine E. coli strain ((A) squares) or a C. coli patient isolate ((B) circles) on days 0
and 1. On day 28 post-challenge, luminal bacterial loads were quantitatively surveyed in distinct
gastrointestinal compartments by culture (in colony-forming units per g; CFU/g). Medians (black bars),
levels of significance (p-values) as determined by the Mann–Whitney U test, and numbers of
culture-positive mice out of the total number of analyzed animals (in parentheses) are given. Data were
pooled from three independent experiments.
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3.2. Kinetic Survey of Clinical Signs Following Peroral C. coli or E. coli Application to Secondary Abiotic
IL-10−/−Mice Lacking TLR4
We further quantitatively surveyed clinical signs following peroral bacterial challenge over time
by applying a standardized scoring system assessing key features of severe human campylobacteriosis,
such as wasting and bloody diarrhea. Whereas mice of either genotype were virtually uncompromised
following E. coli challenge (Supplementary Figure S1A,B), clinical scores were significantly higher
in IL-10−/− mice at days 7 and 28 post-C. coli challenge as compared to unchallenged conditions
(p < 0.001 and p < 0.05, respectively), which also held true for day 7 in TLR4−/− IL-10−/− mice (p < 0.001;
Supplementary Figure S1C,D). Notably, none of the C. coli-infected TLR4−/− IL-10−/− mice and only
18.8% of the IL-10−/− counterparts were suffering from acute campylobacteriosis (as indicated by clinical
scores of at ≥10), whereas 81.8% and 56.3% of infected TLR4−/− IL-10−/− and IL-10−/− mice remained
clinically unaffected, respectively (Supplementary Figure S1C,D). When focusing on the abundance
of fecal blood, however (Figure 3), a maximum of 93.8% of IL-10−/− mice were fecal blood-positive
as early as 5 days post-challenge (Figure 3C), which was the case for 95.5% of TLR4−/− IL-10−/− mice
(Figure 3D), whereas fecal blood was less frequently detected at day 14 and thereafter in the latter as
compared to the former (Figure 3C,D). At the end of the observation period, the fecal blood positivity
rates were lower in IL-10−/− mice lacking TLR4 as compared to IL-10−/− counterparts (18.2% versus
43.8%; Figure 3C,D). Hence, pathogenic C. coli but not commensal E. coli caused differential kinetics in
fecal bleeding in IL-10−/− and TLR4−/− IL-10−/− mice, indicating that TLR4 was involved in mediating
the pathogen-induced signs of intestinal disease.
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Figure 3. Kinetic survey of fecal blood following peroral E. coli or C. coli application to secondary
abiotic IL-10−/− mice lacking TLR4. Secondary abiotic IL-10−/− mice (A,C) and IL-10−/− mice lacking
TLR4 ((B,D) TLR4−/− IL-10−/−) were perorally challenged with either a commensal murine E. coli strain
((A,B) white bars) or a C. coli patient isolate ((C,D) black bars) on the day (d) 0 and d1. Macroscopic or
microscopic detection of fecal blood was surveyed in each mouse over time post-challenge. Bars indicate
the frequencies of fecal blood (in%). Numbers of fecal blood-positive mice out of the total number of
analyzed animals are given in parentheses. Data were pooled from three independent experiments.
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3.3. Role of TLR4 in C. coli-Mediated Colonic Histopathology and Apoptosis
We next assessed potential TLR4-dependent inflammatory responses affecting the large intestines
upon C. coli versus E. coli challenge of secondary abiotic IL-10−/− mice. Therefore, the histopathological
changes within the colon were quantified by applying an established histopathological scoring
system [41]. On day 28 following C. coli infection, higher histopathological scores were assessed in
IL-10−/− when compared to TLR4−/− IL-10−/− mice (p < 0.001) and also when compared to E. coli
challenged IL-10−/− control mice (p < 0.001; Figure 4A; Supplementary Figure S2A).
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Figure 4. Colonic histopathological and epithelial apoptotic cell responses following peroral E. coli
or C. coli application to secondary abiotic IL-10−/− mice lacking TLR4. Secondary abiotic IL-10−/−
mice (open symbols) and IL-10−/− mice lacking TLR4 (TLR4−/− IL-10−/−; closed symbols) were
perorally challenged with either a commensal murine E. coli strain (squares) or a C. coli patient isolate
(circles) on days 0 and 1. On day 28 post-challenge, (A) histopathological changes were qua tified in
hematoxylin and e sin-stained colonic paraffin sections by applying a standar ized scoring system,
as de crib in methods. Furthermore, the average numbers of (B) colonic pithelial apoptotic
(Casp3+) cells were microscopic lly surveyed in six high power fi lds (HPF, 400×magnification) per
animal in immunohistochemically-stained large inte tinal paraffin sections. Medians (black bars),
levels of s gnificance (p-values) as determined by the Kruskal–Wallis test and Dunn’s post-correction,
and numb rs of analyzed ani als (in parentheses) are indicated. Data were pooled from three
independent experiments.
Since apoptosis is a hallmark of C. jejuni-induced murine campylobacteriosis [16], we furthermore
enumerated apoptotic colonic epithelial cells following in situ immunohistochemistry upon necropsy.
In line with the obtained histopathological results, a multifold higher number of caspase3+ apoptotic
cells were found in colonic epithelia at day 28 following C. coli versus E. coli challenge of IL-10−/−
mice (p < 0.05–0.01; Figure 4B; Supplementary Figure S2B). These increases were, however, far less
pronounced in IL-10−/− mice lacking TLR4 as compared to IL-10−/− controls (p < 0.001; Figure 4B;
Supplementary Figure S2B). Hence, TLR4 signaling was involved in mediating C. coli-induced colonic
histopathological and epithelial cell apoptosis upon peroral infection of secondary abiotic IL-10−/− mice.
3.4. TLR4-Dependent Intestinal Immune Cell Responses Induced by C. coli Infection
We next surveyed TLR4-dependent innate and adaptive immune responses in the large intestines
upon the bacterial challenge of secondary abiotic IL-10−/− mice by applying quantitative in situ
immunohistochemistry. On day 28, the numbers of innate immune cell populations, such as F4/80+
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cells macrophages and monocytes, as well as adaptive immune cell subsets, including CD3+ T
lymphocytes, FOXP3+ regulatory T cells, and B220+ B lymphocytes, were higher in the colonic
mucosa and lamina propria of C. coli as compared to E. coli challenged mice of either genotype
(p < 0.01–0.001; Figure 5; Supplementary Figure S2C–F). Upon either bacterial application, colonic
numbers of macrophages and monocytes and of T lymphocytes were lower in TLR4−/− IL-10−/− as
compared to respective IL-10−/− counterparts (p < 0.01–0.001; Figure 5A,B; Supplementary Figure
S2C,D), which also held true for large intestinal B lymphocyte counts at day 28 following C. coli
infection (p < 0.05; Figure 5D; Supplementary Figure S2F). Hence, C. coli induced colonic immune cell
responses in a TLR4-dependent manner.
Microorganisms 2020, 8, x FOR PEER REVIEW 9 of 17 
 
numbers of analyzed animals (in parentheses) are indicated. Data were pooled from three 
independent experiments. 
3.4. TLR4-Dependent Intestinal Immune Cell Responses Induced by C. coli Infection 
We next surveyed TLR4-dependent innate and adaptive immune responses in the large 
intestines upon the bacterial challenge of secondary abiotic IL-10-/- mice by applying quantitative in 
situ immunohistochemistry. On day 28, the numbers of innate immune cell populations, such as 
F4/80+ cells macrophages and monocytes, as well as adaptive immune cell subsets, including CD3+ T 
ly phocytes, FOXP3+ regulatory T cells, and B220+ B lymphocytes, were higher in the colonic mucosa 
and lamina propria of C. coli as compared to E. coli challenged mice of either genotype (p < 0.01–0.001; 
Figure 5; Supplementary Figure S2C–F). Upon either bacterial application, colonic numbers of 
macrophages and monocytes and of T lymphocytes were lower in TLR4-/- IL-10-/- as compared to 
respective IL-10-/- counterparts (p < 0.01–0.001; Figure 5A,B; Supplementary Figure S2C,D), which also 
held true for large intestinal B lymphocyte counts at day 28 following C. coli infection (p < 0.05; Figure 
5D; Supplementary Figure S2F). Hence, C. coli induced colonic immune cell responses in a TLR4-
dependent manner. 
 
Figure 5. Colonic immune cell responses following peroral E. coli or C. coli application to secondary 
abiotic IL-10-/- mice lacking TLR4. Secondary abiotic IL-10-/- mice (open symbols) and IL-10-/- mice 
lacking TLR4 (TLR4-/- IL-10-/-; closed symbols) were perorally challenged with either a commensal 
murine E. coli strain (squares) or a C. coli patient isolate (circles) on days 0 and 1. On day 28 post-
Figure 5. Colonic immune cell responses following peroral E. coli or C. coli application to secondary abiotic
IL-10−/− mice lacking TLR4. Secondary abiotic IL-10−/− mice (open symbols) and IL-10−/− mice lacking
TLR4 (TLR4−/− IL-10−/−; closed symbols) were perorally challenged with either a commensal murine E. coli
strain (squares) or a C. coli patient isolate (circles) on days 0 and 1. On day 28 post-challenge, the average
numbers of (A) macrophages and monocytes (F4/80+), (B) T lymphocytes (CD3+), (C) regulatory T cells
(FOXP3+), and (D) B lymphocytes (B220+) were microscopically surveyed from six high power fields (HPF,
400×magnification) per animal in immunohistochemically-stained colonic paraffin sections. Medians
(black bars), levels of significance (p-values) as determined by (A,B) the one-way ANOVA and Tukey’s
post-correction and (C,D) the Kruskal–Wallis test and Dunn’s post-correction, and the numbers of analyzed
animals (in parentheses) are indicated. Data were pooled from three independent experiments.
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3.5. TLR4 is Involved in Mediating Intestinal and Extra-Intestinal Pro-Inflammatory Responses Following
C. coli Infection of Secondary Abiotic IL-10−/− Mice
We next addressed whether intestinal pro-inflammatory mediator secretion upon bacterial
application to IL-10−/− mice also occurred TLR4 dependently. In C. coli, as compared to E. coli,
challenged IL-10−/− but not TLR4-deficient IL-10−/− mice, higher colonic IFN-γ concentrations could
be measured (p < 0.05; Figure 6A), which also held true for NO and TNF-α secretion in MLN at
day 28 post-challenge (p < 0.01 and p < 0.05, respectively; Figure 6B,C). Moreover, IFN-γ and NO
concentrations were lower in ex vivo biopsies taken from colon and MLN, respectively, of C. coli-infected
TLR4−/− IL-10−/− as compared to IL-10−/− control mice (p < 0.001; Figure 6A,B).
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Furthermore, a trend towards lower serum TNF-α levels could be observed at day 28 following C. 
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Figure 6. Intestinal pro-inflammatory mediator responses following peroral E. coli or C. coli application
to secondary abiotic IL-10−/− mice lacking TLR4. Secondary abiotic IL-10−/− mice (open symbols) and
IL-10−/− mice lacking TLR4 (TLR4−/− IL-10−/−; closed symbols) were perorally challenged with either a
commensal murine E. coli strain (squares) or a C. coli patient isolate (circles) on days 0 and 1. On day 28
post-challenge, pro-inflammatory mediators, such as (A) IFN-γ, (B) nitric oxide (NO), and (C) TNF-α
were determined in ex vivo biopsies taken from the colon (A) and mesenteric lymph nodes (MLN;
(B,C)). Medians (black bars), levels of significance (p-values) as determined by the Kruskal–Wallis
test and Dunn’s post-correction, and the numbers of analyzed animals (in parentheses) are indicated.
Definite outliers were removed after identification with Grubb’s test (α = 0.001). Data were pooled
from three independent experiments. IFN-γ, interferon-gamma; TNF, tumor necrosis factor.
We further asked whether TLR4-dependent pro-inflammatory mediator responses were restricted
to the intestinal tract or could also be observed in extra-intestinal, including systemic tissue sites. IFN-γ
concentrations in livers were higher in 28 days following C. coli as compared to E. coli application
to IL-10−/− mice (p < 0.01; Figure 7A), whereas lower hepatic IFN-γ levels could be obtained from
C. coli-infected TLR4−/− IL-10−/− versus IL-10−/− control mice (p < 0.05; Figure 7A). In serum samples
taken from both C. coli-infected IL-10−/− mice lacking TLR4 and IL-10−/− counterparts, lower TNF-α
concentrations were measured as compared to the respective E. coli cohorts (p < 0.01–0.05; Figure 7B).
Furthermore, a trend towards lower serum TNF-α levels could be observed at day 28 following C. coli
infection of TLR4−/− IL-10−/− as compared to IL-10−/− mice (n.s.; Figure 7B). Hence, upon C. coli
infection of secondary abiotic IL-10−/− mice, TLR4-dependent pro-inflammatory mediator responses
could be observed in intestinal and extra-intestinal tissue sites, including the liver.
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Figure 7. Extra-intestinal including systemic pro-inflammatory cytokine responses following peroral
E. coli or C. coli application to secondary abiotic IL-10−/− mice lacking TLR4. Secondary abiotic IL-10−/−
mice (open symbols) and IL-10−/− mice lacking TLR4 (TLR4−/− IL-10−/−; closed symbols) were perorally
challenged with either a commensal murine E. coli strain (squares) or a C. coli patient isolate (circles) on
days 0 and 1. On day 28 post-challenge, (A) hepatic IFN-γ and (B) serum TNF-α concentrations were
measured. Medians (black bars), levels of significance (p-values) as determined by the Kruskal–Wallis
test and Dunn’s post-correction, and numbers of analyzed animals (in parentheses) are indicated.
Definite outliers were removed after identification with Grubb’s test (α = 0.001). Data were pooled
from three independent experiments.
4. Discussion
C. coli constitutes the second most prevalent causative agent of human Campylobacter infections
after C. jejuni and was recently reported to accoun for appr ximately 10% of the confirmed
campylobacteriosis cases in the Euro ean Union [8]. Yet, little is known about the crosstalk betwe n
C. coli and the immune system of the vertebrate host, and he lack of m lecular data concerning acterial
fact rs triggering campylobacteriosis underlines t e urgent ne d for a convenient murine model of
C. oli infecti n. In the present study, we, therefore, analyzed the pathog nic potential of C. coli in th
secondary abiotic IL-10−/− murine infection model, which w s successfully established and further
optimized as e of the valid clinical i models for acute C. jejuni infection, mimicking key f atures
symptoms of severe campylobacteriosis in hu ans. This acute infe tion and i flammation odel has
unrav led the major role of LOS in C. jejuni-indu ed immunopathologies and is nowadays used for
the evaluation an validation of novel ther peutic intervention strategies against ca pylobacteriosi ,
s shown in recent tudies [46–49]. Whereas several in vitro in stigations have p oven that C. jejuni
LOS activ tes TLR4 in different avian, muri e, and human cell lines [19,50,51], only one study to the
best of our knowledge revealed that a C. coli chicken isolate coul activate TLR4 in vitro [20].
I the present stud , w provided evid nce for TLR4-dependent C. coli vertebrate-host interactions
in vivo and determined the pathogenic potential of C. coli by comparison of data obtained from
colonization of mice with an apathogenic commensal E. coli isolate. R sults indicated that both C. coli
and E. c li stably colonized the small and large intestines f IL-10−/− mice with high loads up to
four weeks post-challenge in a TLR4-independent man er. Stable bacterial establishment within the
intestinal lumen w s accompanied by an bu ance of fecal blood in mice of either genotype that had
been challenged with C. coli as oppose to E. coli, which was most promin nt wit in the first week.
Th finding that C. coli but not E. coli induced signs of intestinal inflammation proved th pathogenic
potential of C. coli, which was mediated by the barrier-breaking properties, such as motility, adhesion,
and invasion, as demonstrated earlier for C. jejuni in the ame muri e model of infection [52,53].
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In TLR4-deficient IL-10−/− mice, however, the maximum fecal blood positivity rates occurred two
days later than in infected IL-10−/− counterparts (day 5 versus day 7 p.i.), whereas in the later stage,
i.e., from week two to four of C. coli infection, fecal blood could less frequently be detected in the former
versus the latter. The role of TLR4 in C. coli-induced disease outcome is supported by less distinct
histopathological changes in the large intestinal tract and by lower numbers of apoptotic epithelial cells
in the colon of TLR4−/− IL-10−/− mice versus IL-10−/− mice at day 28 post-C. coli challenge. Given that
TLR4 can potently induce cell apoptosis [16,17,54], our finding provided evidence that C. coli LOS was
involved in triggering the inflammatory scenario in the intestines upon infection.
The role of LOS as a virulence factor was further confirmed by the findings that C. coli induced
both innate and adaptive immune cell responses in a TLR4-dependent manner. Compared to the
E. coli controls, C. coli-infected IL-10−/− mice displayed elevated levels of innate immune cells, such as
macrophages and monocytes, which also held true for adaptive immune cells populations, including T
and B lymphocytes, which were lower in the TLR4−/− IL-10−/− cohort at day 28 p.i. These results are
supported by our previous studies showing TLR4-dependent immune cell responses upon infection
with C. jejuni 81-176 in the same murine model of infection [17], as well as in secondary abiotic
wildtype mice [16,17]. This confirms that C. coli induces campylobacteriosis similar to C. jejuni in a
TLR4-dependent manner and that LOS plays a major role in C. coli immunopathogenesis.
Furthermore, in line with results derived from C. jejuni-infected IL-10−/− mice suffering from
acute enterocolitis within the first week of infection [17], pro-inflammatory mediator secretion was less
pronounced in intestinal ex vivo biopsies derived from TLR4-deficient IL-10−/− mice as compared to
IL-10−/− controls at day 28 post-C. coli infection. Remarkably, TLR4-dependent immune responses
were not restricted to the intestinal tract but could also be observed in extra-intestinal compartments,
as indicated by less hepatic IFN-γ secretion in C. coli-infected TLR4-deficient IL-10−/− mice as compared
to IL-10−/− mice. Interestingly, no viable C. coli that might have translocated from the lumen of the
inflamed intestines could be isolated from extra-intestinal tissue sites including the blood stream at all.
We could not exclude, however, that translocated bacteria would most likely have been cleared by
the immune system as late as day 28 p.i. One needs to take further into consideration that soluble
C. coli constituents, including LOS, might exert potent pro-inflammatory effects at any extra-intestinal,
including systemic tissue sites [55].
The here presented results are well in line with our very recent study, where we addressed the
role of TLR4 in C. coli-infected mice harboring a complex human gut microbiota [36]. The pathogen
could establish within the gastrointestinal tract of both IL-10−/− and TLR4-deficient IL-10−/− mice until
day 21 p.i., but induced less pronounced immunopathological sequelae in the latter versus the former
upon oral challenge. This study provided the first evidence for the pivotal role of TLR4-dependent
C. coli-host responses in concert with the human gut microbiota [36]. Our actual study involving
microbiota-depleted mice, however, further underlined the important immunopathological role of
TLR4 in mediating pathogenic LOS responses in the absence of any other TLR4 ligands derived from
the commensal gut microbiota.
The auxiliary finding that TLR4-deficient IL-10−/− mice harbored approximately two orders of
magnitude higher C. coli bacterial numbers in the stomach as compared to their IL-10−/− counterparts
provides evidence that TLR4 triggers immune defense mechanisms in the stomach to protect from
pathogens and to maintain intestinal homeostasis [56]. The basolateral expression has been shown
for several TLRs, resulting in less frequent activation by stimuli derived from luminal bacteria [57].
One study revealed that TLR4 is mainly localized at the basolateral surface of the colonic epithelium in
a healthy murine intestine, whereas another study showed that TLR4 is expressed both on the apical
and basolateral surface of the gastric epithelium in mice infected with Helicobacter pylori, which is
closely related to Campylobacter [58,59]. In this scenario, the basolateral expression of TLR4 could
possibly allow C. coli to colonize at higher levels. However, it cannot be excluded that apical TLR4
expression is induced upon an increase in LPS or LOS from Gram-negative pathogens.
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In summary, our results demonstrate that TLR4 signaling is involved in mediating the inflammatory
responses upon C. coli infection in the vertebrate host. However, we cannot exclude that also other
TLRs are participating in the recognition of this pathogen, such as TLR2, TLR5, and TLR9, recognizing
bacterial lipoprotein, flagella, and CpG-DNA, respectively [60]. The C. coli chicken isolate investigated
by Zoete et al. could activate TLR2 and additionally TLR21, which is the receptor recognizing CpG-DNA
in poultry but not TLR5 and TLR9 [20]. Moreover, our group showed earlier that besides TLR4,
also TLR2 and TLR9 play a role in mediating C. jejuni-induced immunopathology [16,17]. In addition,
secondary abiotic IL-10−/− mice deficient in the innate receptor nucleotide-oligonucleotide-domain
2 (Nod2) developed less severe enterocolitis upon peroral C. jejuni infection [35]. Although C. jejuni
is able to evade recognition by TLR5 [61], we do not know whether this also may apply to C. coli.
Furthermore, in order to unravel potential strain-specific host interactions, it is necessary to include
C. coli strains isolated from different sources. One study, for instance, assessed the colonization
abilities of several C. coli strains isolated from three different sources, namely symptomatic carriers,
asymptomatic carriers, and chicken carcasses, and revealed marked functional differences between
the strains, which were most likely source-dependent [62]. It would, therefore, be of high interest
to unravel whether these differences in colonization capacities can be attributed to LOS diversity,
affecting host TLR4 recognition.
5. Conclusions
We further conclude that the here applied infection model of LOS-sensitized secondary abiotic
IL-10−/− mice, which had initially been established to unravel C. jejuni-host interactions, mimicking
severe human campylobacteriosis, can also be used to study the molecular mechanism underlying
C. coli-induced immunopathogenesis and, hence, paves the way to develop therapeutic and prophylactic
options to combat campylobacteriosis as well as post-infectious sequelae.
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Abbreviations
CBA cytometric bead array
CFU colony forming units
HPF high power fields
IFN interferon
IL interleukin
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LOS lipooligosaccharide
LPS lipopolysaccharide
MCP-1 monocyte chemoattractant protein 1





SPF specific pathogen free
TLR Toll-like receptor
TNF tumor necrosis factor
Treg regulatory T cells
WT wildtype
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